Tuesday, September 27, 2022

CATEGORY

News

IGEA Pharma gathers funds for Blue Sky Swisse CBD extraction facility

Preliminary agreement to a €6 million funding commitment for completing a CBD extraction facility in Switzerland has been signed by Netherlands-headquartered IGEA Pharma NV...

Compass Pathways and Albert Labs push on towards psilocybin patient trials

The mycelium of knowledge about the medicinal potential and effectiveness of psilocybin continues to spread, with news from two companies—Compass Pathways and Albert Labs—about...

Subscribe-and-save schemes rolled out for High Tide subsidiaries

Joining the trend for encouraging communities of customers to be established, Blessed CBD has launched a ‘wellness club’ in the UK. The brand is...

OTO partners with Mellow to develop brand in Asia

CBD brand OTO has signed an agreement whereby its products will be distributed in Asia by a division of online CBD and wellness marketplace,...

Tilray launches POLLEN CBD range on Amazon UK

A new brand POLLEN has joined the CBD wellness products available on Amazon UK. It has been launched by Tilray, the Canada-founded, cannabis research,...

London Drugs Commission chair announced from LA

The Mayor of London, Sadiq Khan, has announced who will chair the new London Drugs Commission. Former Lord Chancellor and Justice Secretary Lord Charlie...

Albert Labs moves closer to RWE trial for psilocybin-based drug

Another building block is in place for Albert Labs in its planned ambition to  begin a real world evidence (RWE) trial in the UK...

Psychedelic clinical trials facility to open in London

Psychedelic clinical trials, starting in August with one focusing on the use of psilocybin, will be held at a new dedicated facility in London....

Planned journal for psychedelic medicine research appoints editors

Such is the interest of academic institutions in researching the medicinal properties of psychedelics, including psilocybin, that plans for a new peer-reviewed journal are...

FSA’s approach is no joke for CBD white-label industry

“When is a door not a door?” goes the old joke. “When it’s a-jar,” is the side-splitting reply. We could update it to ask,...